Patent holdings for IPC class C07D 491/052

Total number of patents in this class: 1102

10-year publication summary

85
65
71
72
72
60
82
91
80
61
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2056
36
Bristol-myers Squibb Company
4849
24
Merck Sharp & Dohme LLC
3753
21
Novartis AG
10721
16
Eli Lilly and Company
3902
16
Merck Patent GmbH
5767
15
F. Hoffmann-La Roche AG
7948
14
Boehringer Ingelheim International GmbH
4640
13
Vertex Pharmaceuticals Incorporated
1626
13
Daiichi Sankyo Company, Limited
1877
13
Takeda Pharmaceutical Company Limited
2710
12
FUJIFILM Corporation
29696
10
Arbutus Biopharma Corporation
177
10
Genentech, Inc.
4009
9
Merck Sharp & Dohme Corp.
2190
9
Hoffmann-La Roche Inc.
3478
8
The Regents of the University of California
20108
8
Janssen Pharmaceutica N.V.
3367
8
Emory University
1639
8
Kadmon Corporation, LLC
100
8
Other owners 831